Mostrar el registro sencillo del ítem

dc.contributor.authorQuiñones Vico, María Isabel 
dc.contributor.authorUbago Rodríguez, Ana Dolores 
dc.contributor.authorFernández González, Ana
dc.contributor.authorSanabria de la Torre, Raquel 
dc.contributor.authorSierra Sánchez, Álvaro
dc.contributor.authorMontero Vílchez, Trinidad
dc.contributor.authorSánchez Díaz, Manuel
dc.contributor.authorArias Mediano, José Luis 
dc.contributor.authorArias Santiago, Salvador Antonio 
dc.date.accessioned2024-09-05T10:23:04Z
dc.date.available2024-09-05T10:23:04Z
dc.date.issued2024-08-02
dc.identifier.citationQuiñones Vico, M.I. et. al. 2024;19:7895-7926. [https://doi.org/10.2147/IJN.S469724]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/93998
dc.description.abstractPseudomonas aeruginosa (P. aeruginosa) is a common nosocomial pathogen that can cause severe infections in critically ill patients. Due to its resistance to multiple drugs, it is challenging to treat, which can result in serious illness and death. Conventional treatments for infected wounds often involve the topical or systemic application of antibiotics, which can lead to systemic toxicity and the development of drug resistance. The combination of wound dressings that promote wound healing with nanoparticles (NPs) represents a revolutionary strategy for optimizing the safety and efficacy of antibiotics. This review assesses a systematic search to identify the latest approaches where the evaluation of wound dressings loaded with antibiotic NPs is conducted. The properties of NPs, the features of wound dressings, the antimicrobial activity and biocompatibility of the different strategies are analyzed. The results indicate that most research in this field is focused on dressings loaded with silver NPs (57.1%) or other inorganic materials (22.4%). Wound dressings loaded with polymeric NPs and carbon-based NPs represent 14.3% and 6.1% of the evaluated studies, respectively. Nevertheless, there are no clinical trials that have evaluated the efficacy of NPs-loaded wound dressings in patients. Further research is required to ensure the safety of these treatments and to translate the findings from the bench to the bedside.es_ES
dc.description.sponsorshippredoctoral fellowship (FPU19/05455, BOE 22 October 2019) from the Ministry of Science, Innovation and Universities of Spaines_ES
dc.description.sponsorshipBiomedicine program at the University of Granadaes_ES
dc.description.sponsorshipAndalusian Regional Government (PIGE-0242-2019) and the Carlos III Health Institute (PI17/02083)es_ES
dc.language.isoenges_ES
dc.publisherTaylor and Francis Groupes_ES
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjecthydrogeles_ES
dc.subjectskin infectiones_ES
dc.subjectwound dressinges_ES
dc.titleAntibiotic Nanoparticles-Loaded Wound Dressings Against Pseudomonas aeruginosa’s Skin Infection: A Systematic Reviewes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.2147/IJN.S469724
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional